Resistance reversal effect of a novel taxane compound NPB304 and its collaboration with verapamil

Mei MEI; Yi ZHANG; Jin-Hong REN; Dan XIE; Yu-Fei JIA; Jin-Ping HU; Yan LI; Jun-Gui DAI; Xiao-Guang CHEN.
Acta Pharmaceutica Sinica ; (12): 1279-1288, 2014.
Artículo en Zh | WPRIM | ID: wpr-299138

Documentos relacionados

  1. [Resistance reversal effect of a novel taxane compound NPB304 and its collaboration with verapamil].
  2. Carnosine Potentiates Doxorubicin-Induced Cytotoxicity in Resistant NCI/ADR-RES Cells by Inhibiting P-Glycoprotein-In Silico and In Vitro Evidence.
  3. Low-Dose Rifabutin Increases Cytotoxicity in Antimitotic-Drug-Treated Resistant Cancer Cells by Exhibiting Strong P-gp-Inhibitory Activity.
  4. Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition.
  5. Metabolomics analysis of multidrug resistance in colorectal cancer cell and multidrug resistance reversal effect of verapamil.
  6. TM2, a novel semi-synthetic taxoid, exerts anti-MDR activity in NSCLC by inhibiting P-gp function and stabilizing microtubule polymerization.
  7. Recent Advances on P-Glycoprotein (ABCB1) Transporter Modelling with In Silico Methods.
  8. Overexpression of tensin homolog deleted on chromosome ten (PTEN) by ciglitazone sensitizes doxorubicin-resistance leukemia cancer cells to treatment.
  9. A glutathione responsive nitric oxide release system based on charge-reversal chitosan nanoparticles for enhancing synergistic effect against multidrug resistance tumor.
  10. Drug resistance in multiple myeloma.